Follow
Mehmet Hepgur
Mehmet Hepgur
Attending Hematologist/Oncologist, Comprehensive Cancer Center at Broward Health Medical Center
Verified email at usc.edu
Title
Cited by
Cited by
Year
Multiparameter flow cytometry for the diagnosis and monitoring of small GPI‐deficient cellular populations
M Battiwalla, M Hepgur, D Pan, PL McCarthy, MS Ahluwalia, ...
Cytometry Part B: Clinical Cytometry 78 (5), 348-356, 2010
342010
Medical management of pneumatosis intestinalis in patients undergoing allogeneic blood and marrow transplantation
M Hepgur, MS Ahluwalia, N Anne, J Thomas, H Liu, MD Schiff, PA Loud, ...
Bone marrow transplantation 46 (6), 876-879, 2011
322011
Tivozanib in the treatment of renal cell carcinoma
M Hepgur, S Sadeghi, TB Dorff, DI Quinn
Biologics: Targets and Therapy, 139-148, 2013
302013
Atypical haemolytic-uraemic syndrome due to heterozygous mutations of CFH/CFHR1–3 and complement factor H 479
P Chaudhary, M Hepgur, S Sarkissian, RJH Smith, IC Weitz
Blood Transfusion 12 (1), 111, 2014
102014
Durable complete remission from castration-resistant prostate cancer with sipuleucel-T after estrogen withdrawal
TB Dorff, C Wilkins, M Hepgur, DI Quinn
Clinical genitourinary cancer 12 (2), e55-e58, 2014
32014
Changes in circulating tumor cells (CTC) and markers of inflammation after sipuleucel-T treatment.
M Hepgur, TB Dorff, J Cai, JK Pinski, M Reed, M Luther, B Chan, DI Quinn
Journal of Clinical Oncology 31 (6_suppl), 40-40, 2013
12013
Atypical presentation of vaginal GvHD with abdominal pain crises
MG Hepgur, P Paplham, A Ghomi, C Vyas, PL McCarthy, S Smiley, ...
Biology of Blood and Marrow Transplantation 16 (2), S315, 2010
12010
Dynamic changes in biomarkers for immune response to sipuleucel-t (SipT) for metastatic castrate-resistant prostate cancer (mCRPC).
DIQ Mehmet Faith Hepgur, Tanya B. Dorff, Jie Cai, Mary Reed, Betty Chan
J Clin Oncol 33 (suppl 7), abstr 181, 2015
2015
Identification of biologic and inflammatory markers for predicting clinical responses to sipuleucel-T in CRPC.
MF Hepgur, TB Dorff, L Brining, J Cai, JK Pinski, M Reed, M Luther, ...
Journal of Clinical Oncology 32 (4_suppl), 134-134, 2014
2014
Clinical and biologic factors for immune response to sipuleucel-T (SipT) for metastatic castrate-resistant prostate cancer (mCRPC).
MF Hepgur, TB Dorff, L Brining, J Cai, JK Pinski, M Reed, M Luther, ...
Journal of Clinical Oncology 32 (4_suppl), 219-219, 2014
2014
A Novel Hybrid CFH/CFHR1–3 Gene in Atypical Hemolytic Uremic Syndrome
MF Hepgur, P Chaudhary, S Sarkissian, RJH Smith, H Liebman, IC Weitz
Blood 120 (21), 4644, 2012
2012
Early Complete Donor Lymphoid Chimerism With Fludarabine, Melphalan And Low Dose (400 CGy) Total Body Irradiation Reduced Intensity Conditioning
M Hepgur, N Saito, T Hahn, P Starostik, P Wallace, B Bambach, ...
Biology of Blood and Marrow Transplantation 16 (2), S291-S292, 2010
2010
Solitary Splenic Metastasis from Primary Non Small Cell Carcinoma of the Lung
Hepgur M
International Journal of Hematology and Oncology 20 (4), 241-244, 2010
2010
The system can't perform the operation now. Try again later.
Articles 1–13